Progesterone Capsule
Product Images NDC 42291-784

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Progesterone (NDC 42291-784). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100 (784 01)

100 (784 01)
This is a prescription medication for Progesterone in the form of capsules. It is important not to use this medication if allergic to peanuts. Each capsule contains 100 mg of micronized progesterone. The usual dosage information can be found in the package insert. It is recommended to store this medication at room temperature and keep it away from excessive moisture. The manufacturer is AVKARE Pulaski. This medication is only for prescription use.*
FDA Label Image

30 (784 30)

30 (784 30)
This is a description of a medication labeled as NDC 22291 784-30 Beonly™ capsules, each containing 100 mg of micronized progesterone. The medication is manufactured for Avkare Pulaski and is stored in a controlled room temperature between 68°F to 77°F. The expiration date is April 2024, and it comes in a light-resistant container as per USP standards. The text also indicates that the medication should be kept out of reach of children and not used if allergic to peanuts. Pharmacists are advised to provide patient information separately.*
FDA Label Image

100 (785 01)

100 (785 01)
This is a description for progesterone capsules. The capsules contain 200 mg of micronized progesterone and are manufactured for AVKARE Pulask. The usual dosage instructions can be found in the package insert. It is advised to store the capsules at temperatures between 20°C to 25°C (68°F to 77°F) to protect them from excessive moisture. The expiration date is listed as February 2024. It is important to keep this medication and all drugs out of reach of children. The product is made in Spain.*
FDA Label Image

30 (785 30)

30 (785 30)
This text seems to be a detailed description of a medication. It mentions information about a capsule containing 200 mg of miconazole, manufactured by AVKARE. It also includes storage instructions, expiration date, and a warning about keeping the drug away from children and not using it if the seal is broken. Additionally, there is a note for pharmacists to provide patient information separately. Overall, this text provides essential details about the medication and its proper usage.*
FDA Label Image

Figure 1 (Figure 1)

Figure 1 (Figure 1)
This text provides information about a study involving Conjugated Estrogens and Conjugated Estrogens Plus Micronized Progesterone given cyclically to patients over 36 months. The data shows the number of patients remaining on the medication at 12, 24, and 36 months.*
FDA Label Image

Chemical Structure (Prog Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.